Ulodesine succinate anhydrous
Ulodesine (BCX4208) is a potent, once-daily oral PNP inhibitor with a 0.5 nM IC50, developed to lower serum uric acid for gout. It is also being investigated in early clinical trials for psoriasis, with research applications in purine metabolism studies both in vitro and in vivo.
Product Specifications
CAS Number
1246200-39-4
Smiles
OC (CCC (O) =O) =O.O=C (N=CN1) C2=C1C (CN3C[C@@H] ([C@H] (C3) O) CO) =CN2.O=C (N=CN4) C5=C4C (CN6C[C@@H] ([C@H] (C6) O) CO) =CN5
Molecular Formula
C12H16N4O3 1/2C4H6O4
Molecular Weight
323.325
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog